Study of proteomics for identification of novel prognostic biomarkers in patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma undergoing surgical resection

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220113002

Enrollment

115

Registered

2022-01-13

Start date

2021-08-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma and Intrahepatic cholangiocarcinoma Hepatocellular carcinoma, Intrahepatic cholangiocarcinoma, Biomarkers, Proteomics, Prognosis

Interventions

hepatocellular carcinoma ,intrahepatic cholangiocarcinoma

Basic Science,Basic Science

Patients with hepatocellular carcinoma ,Patients with intrahepatic cholangiocarcinoma

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma undergoing surgical resection from King Chulalongkorn Memorial Hospital

Exclusion criteria

Exclusion criteria: 1. Smoking 2. Congenital disease 3. A patient who had a bowel resection

Design outcomes

Primary

Measure	Time frame
diagnostic biomarker first visit western blot	—

Secondary

Measure	Time frame
prognostic marker first visit ELISA	—

Countries

Thailand

Contacts

Public ContactPongserath Sirichindakul

Chulalongkorn University

pongserath.s@gmail.com0 2256 4117

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026